Want to join the conversation?
$TMO 2Q15 Call: Analytical Instruments Segment revenue was $777MM in the second quarter of 2015, down 2% compared with revenue of $793MM in the second quarter of 2014 and organic revenue growth was 4%. Segment adjusted operating margin increased to 18.0%, versus 16.4% in the 2014 quarter, up 160BP.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?